Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH). According to a Schedule 13G filed with the Securities and Exchange Commission, the fund now owns about 1.3 million shares of the company’s Common Stock, which account for 5.7% of its total shares outstanding. On that same date, Matthew Drapkin and Steven R. Becker’s Becker Drapkin Management declared a purchase of PowerSecure International, Inc. (NYSE:POWR) securities. According to an amended Schedule 13D filing, the fund acquired on October 1 an aggregate of 3,000 covered call options relating to 300,000 shares of Common Stock. In addition, Becker Drapkin Management owns 1.39 million shares of Common Stock, which represent 6.3% of the company’s outstanding stock.
PowerSecure International, Inc. (NYSE:POWR) is a $228.6 million market cap provider of products and services to electric utilities and to their commercial, institutional and industrial customers. According to Becker Drapkin Management’s most recent 13D filing, the fund acquired 3,000 covered call options, with an exercise price of $10.00, for an aggregate price of $75,000. These options relate to 300,000 shares of Common Stock and expire on October 18, 2014, and were purchased to cover 3,000 outstanding call options previously sold by the fund – which also expired on October 18.
Becker Drapkin Management’s 1.39 million shares make it the largest institutional shareholder at PowerSecure International, Inc. (NYSE:POWR), amongst those we track. The fund first started a position in the company over the second quarter of the year. Same was the case of Philip Hempleman’s Ardsley Partners, which acquired, over the second quarter, 320,000 shares of Common Stock, worth more than $3 million.
Despite the relative bullishness mentioned above, Becker Drapkin Management has been trimming its stake in PowerSecure International, Inc. (NYSE:POWR) lately. Although its holdings are larger now than they were by the end of the second quarter, they are smaller than in late-July, when it declared holding 1.64 million shares.
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is a $39.3 million market cap biopharmaceutical company focused on developing and commercializing therapeutics to treat serious diseases associated with inflammation and autoimmune diseases. On late-September, Kevin Kotler’s Broadfin Capital augmented its bet on the company by almost 70%, and now owns 1.3 million shares of Common Stock, which account for 5.7% of the company’s total shares outstanding.
This stake makes of Broadfin Capital one of the largest institutional investors in Anthera Pharmaceuticals Inc (NASDAQ:ANTH). Two funds with even larger wages are Jeffrey Jay And David Kroin’s Great Point Partners, which last disclosed ownership of 1.5 million shares, worth more than $5 million, and James E. Flynn’s Deerfield Management, with 1.69 million shares of Common Stock.
Disclosure: Javier Hasse holds no positions in any stocks or funds mentioned
Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.
